10-Q: Huntsman Reports Q3 Loss Amid Restructuring, Dividend Cut

Huntsman Corporation reported a net loss of $25 million for Q3 2025 and a significant increase in nine-month losses, alongside a 65% dividend reduction and ongoing restructuring efforts.

Summary

• Net loss attributable to Huntsman Corporation for the three months ended September 30, 2025, was $25 million, compared to a net loss of $33 million in the prior year period.
• For the nine months ended September 30, 2025, net loss attributable to Huntsman Corporation significantly increased to $188 million, from $48 million in the same period of 2024.
• Total revenues decreased by 5% to $1,460 million for the three months ended September 30, 2025, and by 6% to $4,328 million for the nine months ended September 30, 2025, compared to the respective prior year periods.
• Gross profit declined by 13% for both the three-month and nine-month periods, reaching $204 million and $587 million, respectively.
• Operating income for the three months ended September 30, 2025, was $6 million, an 86% decrease from $42 million in the prior year, while the nine-month period saw an operating loss of $72 million, a significant decline from an operating income of $38 million in 2024.
• Adjusted EBITDA decreased by 28% to $94 million for the three months and by 30% to $240 million for the nine months ended September 30, 2025.
• Net cash provided by operating activities from continuing operations increased by 75% to $221 million for the nine months ended September 30, 2025, compared to $126 million in 2024.
• Free cash flow from continuing operations improved to $105 million for the nine months ended September 30, 2025, from a use of cash of $7 million in the prior year period.
• The Board of Directors declared a cash dividend of $0.0875 per share on November 3, 2025, representing a 65% decrease from the previous dividend of $0.25 per share.
• Restructuring, impairment, and plant closing costs increased significantly to $137 million for the nine months ended September 30, 2025, up from $20 million in 2024, driven by facility closures and organizational realignments.
• A final award of approximately $66 million was received from the Praxair/Linde litigation, resulting in $33 million income net of legal fees recognized in the first quarter of 2025.

Sentiment

Score: 3

Explanation: The company experienced significant declines in revenues, gross profit, operating income, and adjusted EBITDA, leading to a substantial increase in net loss for the nine-month period. The 65% dividend cut and amendments to debt covenants reflect financial strain, despite an improvement in free cash flow driven partly by reduced capital expenditures and working capital management rather than strong operational earnings.

Positives

• Net cash provided by operating activities from continuing operations increased by 75% to $221 million for the nine months ended September 30, 2025, compared to $126 million in 2024.
• Free cash flow from continuing operations improved significantly to $105 million for the nine months ended September 30, 2025, from a use of cash of $7 million in the prior year period.
• A final award of approximately $66 million was received from the Praxair/Linde litigation, including $23.5 million in interest, with $33 million recognized as income net of legal fees.
• Capital expenditures from continuing operations decreased to $116 million for the nine months ended September 30, 2025, from $133 million in the prior year, indicating reduced spending.
• Cash and cash equivalents increased by $128 million to $468 million as of September 30, 2025, from $340 million at December 31, 2024.

Negatives

• Net loss attributable to Huntsman Corporation for the nine months ended September 30, 2025, significantly increased to $188 million, compared to a loss of $48 million in the same period of 2024.
• Total revenues decreased by 5% for the three months and 6% for the nine months ended September 30, 2025, primarily due to lower average selling prices and sales volumes in key segments.
• Gross profit declined by 13% for both the three-month and nine-month periods, reflecting reduced profitability.
• Operating income for the three months ended September 30, 2025, decreased by 86% to $6 million, and the nine-month period shifted to an operating loss of $72 million from an income of $38 million.
• Adjusted EBITDA decreased by 28% for the three months and 30% for the nine months ended September 30, 2025, indicating a significant decline in operational profitability.
• The Board of Directors declared a cash dividend of $0.0875 per share on November 3, 2025, a 65% decrease from the previous dividend, signaling financial strain.
• Restructuring, impairment, and plant closing costs increased substantially to $137 million for the nine months ended September 30, 2025, up from $20 million in 2024.
• Total debt increased to $2,008 million as of September 30, 2025, from $1,835 million at December 31, 2024.
• The Second Amendment to the 2022 Revolving Credit Facility was entered into on May 23, 2025, increasing the maximum permitted leverage ratio and limiting the ability to make restricted payments for equity redemptions during the Covenant Relief Period, indicating tighter financial covenants.

Risks

• The company refers to its Annual Report on Form 10-K for the year ended December 31, 2024, for a comprehensive discussion of risk factors that could materially affect actual results.

Future Outlook

The company expects to incur approximately $9 million in additional contributions to pension and other postretirement benefit plans during the remainder of 2025. Further restructuring expenses of approximately $2 million are expected through the first quarter of 2026 for the Performance Products segment, $16 million through 2027 for the Polyurethanes segment, and $6 million through 2027 for the Advanced Materials segment. Capital expenditures for 2025 are projected to be between $170 million and $180 million.

Industry Context

The Polyurethanes segment experienced less favorable supply and demand dynamics, leading to lower MDI average selling prices. The Performance Products segment faced overall softening market conditions and competitive pressures, contributing to decreased sales volumes and average selling prices.

Corporate Governance

Legal Proceedings

• The Louisiana Supreme Court affirmed a jury verdict in the company's favor in the long-running court battle against Praxair/Linde, resulting in a final award of approximately $66 million, including $23.5 million in interest.

Related Party Transactions

• Related party sales amounted to $25 million for the three months ended September 30, 2025, and $86 million for the nine months ended September 30, 2025.

Stakeholder Impact

• Shareholders are impacted by the significant net losses, the 65% reduction in the cash dividend, and limitations on share repurchases due to debt covenants.
• Employees in Europe are affected by workforce reductions and facility closures as part of restructuring programs in the Performance Products and Polyurethanes segments.
• Creditors are impacted by the increase in total debt and the amendment to the 2022 Revolving Credit Facility, which adjusted leverage ratios and restricted payments.

Next Steps

• Expects to record further restructuring expenses of approximately $2 million through the first quarter of 2026 for the Performance Products segment.
• Expects to record further restructuring expenses of approximately $16 million through 2027 for the Polyurethanes segment.
• Expects to record further restructuring expenses of approximately $6 million through 2027 for the Advanced Materials segment.
• Anticipates capital expenditures between $170 million to $180 million for the full year 2025.
• Plans to make additional contributions of approximately $9 million to pension and other postretirement benefit plans during the remainder of 2025.
• Intends to renew, repay, or extend the majority of short-term debt facilities in the next twelve months.

Key Dates

Recommendation

The company's financial performance for the nine months ended September 30, 2025, shows a substantial increase in net loss and significant declines in revenues, gross profit, operating income, and adjusted EBITDA. The 65% reduction in the cash dividend signals financial distress and a need to conserve capital. While cash flow from operations improved, this appears to be driven by working capital management and reduced capital expenditures rather than underlying operational strength. The amendment to debt covenants further highlights financial pressures. These factors collectively indicate a deteriorating financial outlook and warrant a 'sell' recommendation for investors.

Keywords

Huntsman, chemicals, polyurethanes, performance products, advanced materials, Q3 2025 earnings, SEC 10-Q, restructuring, dividend cut, financial results, MDI, amines, maleic anhydride, epoxy-based polymer formulations